Impact of glycemic variability on coronary and peripheral endothelial dysfunction in patients with coronary artery disease

Klein, 1995, Hyperglycemia and microvascular and macrovascular disease in diabetes, Diabetes Care, 18, 258, 10.2337/diacare.18.2.258 Tominaga, 1999, Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study, Diabetes Care, 22, 920, 10.2337/diacare.22.6.920 Giorgino, 2016, Glucose control and vascular outcomes in type 2 diabetes: is the picture clear?, Diabetes Care, 39, S187, 10.2337/dcS15-3023 Takahashi, 2018, Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome, Cardiovasc Diabetol, 17, 116, 10.1186/s12933-018-0761-5 Pu, 2020, Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: a meta-analysis, Endocrine, 67, 526, 10.1007/s12020-019-02150-1 Wang, 2017, Visit-to-visit variability of fasting plasma glucose and the risk of cardiovascular disease and all-cause mortality in the general population, J Am Heart Assoc, 6, 10.1161/JAHA.117.006757 Zinman, 2018, Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2), Diabetologia, 61, 48, 10.1007/s00125-017-4423-z Ceriello, 2008, Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients, Diabetes, 57, 1349, 10.2337/db08-0063 Kuroda, 2015, Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study, JACC Cardiovasc Interv, 8, 800, 10.1016/j.jcin.2014.11.025 Torimoto, 2013, Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus, Cardiovasc Diabetol, 12, 1, 10.1186/1475-2840-12-1 Akasaka, 2017, Effects of the mean amplitude of glycemic excursions and vascular endothelial dysfunction on cardiovascular events in nondiabetic patients with coronary artery disease, J Am Heart Assoc, 6, 10.1161/JAHA.116.004841 Zhou, 2020, Glycemic variability: adverse clinical outcomes and how to improve it?, Cardiovasc Diabetol, 19, 102, 10.1186/s12933-020-01085-6 Bolinder, 2016, Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicenter, non-masked, randomized controlled trial, Lancet, 388, 2254, 10.1016/S0140-6736(16)31535-5 Saito, 2021, Contemporary coronary drug-eluting and coated stents: a mini-review, Cardiovasc Interv Ther, 36, 20, 10.1007/s12928-020-00731-w Saito, 2020, Clinical expert consensus document on standards for measurements and assessment of intravascular ultrasound from the Japanese association of cardiovascular intervention and therapeutics, Cardiovasc Interv Ther, 35, 1, 10.1007/s12928-019-00625-6 Sonoda, 2020, Current clinical use of intravascular ultrasound imaging to guide percutaneous coronary interventions, Cardiovasc Interv Ther, 35, 30, 10.1007/s12928-019-00603-y Fujii, 2020, Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography, Cardiovasc Interv Ther, 35, 13, 10.1007/s12928-019-00626-5 Kurogi, 2021, Optical coherence tomography-guided percutaneous coronary intervention: a review of current clinical applications, Cardiovasc Interv Ther, 36, 169, 10.1007/s12928-020-00745-4 Sheikh, 2015, Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease, Circulation, 132, e242, 10.1161/CIRCULATIONAHA.115.017254 Ludmer, 1986, Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries, N Engl J Med, 315, 1046, 10.1056/NEJM198610233151702 Kitahara, 2011, Effect of pioglitazone on endothelial dysfunction after sirolimus-eluting stent implantation, Am J Cardiol, 108, 214, 10.1016/j.amjcard.2011.03.029 Aoki, 2016, Protective effect of angiotensin II receptor blocker and calcium channel blocker on endothelial vasomotor function after everolimus-eluting stent implantation, J Cardiol, 67, 236, 10.1016/j.jjcc.2015.05.006 Hofma, 2006, Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation, Eur Heart J, 27, 166, 10.1093/eurheartj/ehi571 Fuke, 2007, Impaired endothelial vasomotor function after sirolimus-eluting stent implantation, Circ J, 71, 220, 10.1253/circj.71.220 Suzuki, 2020, Clinical expert consensus document on quantitative coronary angiography from the Japanese association of cardiovascular intervention and therapeutics, Cardiovasc Interv Ther, 35, 105, 10.1007/s12928-020-00653-7 Sauder, 2014, Test-retest reliability of peripheral arterial tonometry in the metabolic syndrome, Diabetes Vasc Dis Res, 11, 201, 10.1177/1479164114525971 Saito, 2017, Preoperative assessment of endothelial function for prediction of adverse events after cardiovascular surgery, Circ J, 82, 118, 10.1253/circj.CJ-17-0567 Saito, 2017, Night-time blood pressure variability negatively correlated with reactive hyperemia index, Int J Cardiol, 230, 332, 10.1016/j.ijcard.2016.12.110 Saito, 2019, Relation of elevated serum uric acid level to endothelial dysfunction in patients with acute coronary syndrome, J Atheroscler Thromb, 26, 362, 10.5551/jat.45179 2020, American diabetes association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020, Diabetes Care, 43, S14 Kovatchev, 2016, Glucose variability: timing, risk analysis, and relationship to hypoglycemia in diabetes, Diabetes Care, 39, 502, 10.2337/dc15-2035 Battelino, 2019, Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range, Diabetes Care, 42, 1593, 10.2337/dci19-0028 Zhou, 2020, Glycemic variability: adverse clinical outcomes and how to improve it?, Cardiovasc Diabetol, 19, 102, 10.1186/s12933-020-01085-6 Farkouh, 2015, Blood glucose variability: a new metric for interventional cardiology?, JACC Cardiovasc Interv, 8, 812, 10.1016/j.jcin.2015.01.021 Gohbara, 2016, Glycemic variability on continuous glucose monitoring system correlates with non-culprit vessel coronary plaque vulnerability in patients with first-episode acute coronary syndrome - optical coherence tomography study, Circ J, 80, 202, 10.1253/circj.CJ-15-0790 Terashima, 2012, Protective effect of telmisartan against endothelial dysfunction after coronary drug-eluting stent implantation in hypertensive patients, JACC Cardiovasc Interv, 5, 182, 10.1016/j.jcin.2011.09.022 Ito, 2019, The impact of intraday glucose variability on coronary artery spasm in patients with dysglycemia, Heart Vessels, 34, 1250, 10.1007/s00380-019-01353-w Saito, 2016, Intracoronary acetylcholine provocation testing - omission of the 20µg dose is feasible in patients without coronary artery spasm in the other coronary artery, Circ J, 80, 1820, 10.1253/circj.CJ-16-0344 Tateishi, 2018, Safety and usefulness of acetylcholine provocation test in patients with no culprit lesions on emergency coronary angiography, Int J Cardiol, 269, 27, 10.1016/j.ijcard.2018.06.108 Suzuki, 2021, Role of acetylcholine spasm provocation test as a pathophysiological assessment in nonobstructive coronary artery disease, Cardiovasc Interv Ther, 36, 39, 10.1007/s12928-020-00720-z Bonetti, 2004, Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia, J Am Coll Cardiol, 44, 2137, 10.1016/j.jacc.2004.08.062 Reriani, 2011, Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials, Eur J Cardiovasc Prev Rehabil, 18, 704, 10.1177/1741826711398430 Benalia, 2019, Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction, Diabetes Metab, 45, 446, 10.1016/j.diabet.2019.01.012 Hamilos, 2008, Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion, J Am Coll Cardiol, 51, 2123, 10.1016/j.jacc.2007.12.059 Whelan, 2000, Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries, Heart, 83, 338, 10.1136/heart.83.3.338 Kim, 2009, A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction, J Am Coll Cardiol, 53, 1653, 10.1016/j.jacc.2009.01.051 Park, 2017, Effect of gemigliptin on glycaemic variability in patients with type 2 diabetes (STABLE study), Diabetes Obes Metab, 19, 892, 10.1111/dom.12869 Lee, 2019, Effect of DPP-IV inhibitors on glycemic variability in patients with T2DM: a systematic review and meta-analysis, Sci Rep, 9, 13296, 10.1038/s41598-019-49803-9